Menstrual Suppression in Adolescents
This review evaluates medical therapies for menstrual suppression in adolescents, detailing their pros and cons to aid providers in selecting appropriate options based on clinical factors and patient preferences.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper is a literature review assessing medical therapies for menstrual suppression in adolescents, aiming to compare available options and outline how to tailor selection to different clinical situations. The authors searched PubMed using terms such as menstrual suppression and adolescents and report that multiple treatments can achieve menstrual suppression, each with specific advantages and disadvantages in the adolescent population. They emphasize that choosing between agents should consider clinical indication, medical eligibility, need for contraception, and patient preferences, while also covering differences among hormonal therapies related to bone health, coagulability, and androgenic adverse effects. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,919 characters
· extracted from
oa-doi-fallback
· 3 sections
· click to expand
Objective
Results
Conclusions
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (79)
- ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent via openalex
- Development and Application of a Physiologically Based Pharmacokinetic Model for Elagolix in the Adult and Adolescent Population via openalex
- Prevention of severe menorrhagia in oncology patients with treatment‐induced thrombocytopenia by luteinizing hormone‐releasing hormone agonist and depo‐medroxyprogesterone acetate via openalex
- Retrospective Review of Norethindrone Use in Adolescents via openalex
- The Induction of Amenorrhoea via openalex
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
- Unscheduled vaginal bleeding with progestin-only contraceptive use via openalex
- doi:10.1097/01.aog.0000175144.08035.74 via openalex
- doi:10.1001/jama.1967.03120180102023 via openalex
- doi:10.1002/14651858.cd009849.pub3 via openalex
- doi:10.1097/aog.0000000000004896 via openalex
- doi:10.1016/j.jpag.2019.09.002 via openalex
- doi:10.1542/peds.2016-3992 via openalex
- doi:10.1016/j.jpag.2013.12.011 via openalex
- doi:10.1097/gco.0b013e3283094b79 via openalex
- doi:10.1542/peds.73.4.445 via openalex
- doi:10.1002/14651858.cd006261.pub2 via openalex
- doi:10.1016/j.contraception.2017.03.004 via openalex
- doi:10.1542/peds.2016-0295 via openalex
- doi:10.1097/grf.0b013e3181f96cb1 via openalex
- doi:10.1016/s0010-7824(97)00156-x via openalex
- doi:10.1097/aog.0000000000001031 via openalex
- W11645595 via openalex
- W186462820 via openalex
- W1419805799 via openalex
- doi:10.1016/s0010-7824(01)00302-x via openalex
- doi:10.1016/j.contraception.2007.01.014 via openalex
- doi:10.1016/j.ajog.2011.09.021 via openalex
- doi:10.1530/eje.0.151s047 via openalex
- doi:10.1089/lgbt.2014.0018 via openalex
- doi:10.1016/j.jpag.2016.05.012 via openalex
- doi:10.1016/j.fertnstert.2016.09.027 via openalex
- doi:10.1016/j.contraception.2009.02.005 via openalex
- doi:10.1016/s0029-7844(03)00014-0 via openalex
- doi:10.1093/humupd/dmt038 via openalex
- doi:10.1016/j.contraception.2007.10.005 via openalex
- doi:10.1210/er.2012-1008 via openalex
- doi:10.1097/01.aog.0000238343.62063.22 via openalex
- doi:10.1097/aog.0000000000003411 via openalex
- doi:10.1016/j.jpag.2018.02.130 via openalex
- doi:10.1210/jc.2007-0044 via openalex
- doi:10.1097/grf.0b013e318159c20a via openalex
- doi:10.1371/journal.pone.0231856 via openalex
- doi:10.1016/j.jadohealth.2006.03.011 via openalex
- W2418459095 via openalex
- doi:10.1097/grf.0000000000000356 via openalex
- doi:10.1016/j.jpag.2014.02.015 via openalex
- doi:10.1001/jamapediatrics.2019.5040 via openalex
- doi:10.1097/aog.0b013e318277c93b via openalex
- doi:10.1016/j.contraception.2004.11.007 via openalex
- doi:10.1016/j.yobg.2012.06.157 via openalex
- doi:10.1007/s00737-010-0201-3 via openalex
- doi:10.3389/fped.2023.1170025 via openalex
- doi:10.1016/j.ajog.2020.01.059 via openalex
- doi:10.1097/aog.0b013e3181842071 via openalex
- doi:10.1016/j.fertnstert.2011.12.003 via openalex
- doi:10.1097/01.aog.0000160430.61799.f6 via openalex
- doi:10.7759/cureus.57713 via openalex
- doi:10.1002/14651858.cd006586.pub4 via openalex
- doi:10.1001/archpedi.159.2.139 via openalex
- doi:10.1016/j.jpag.2005.03.002 via openalex
- doi:10.1007/s40268-023-00419-5 via openalex
- doi:10.1097/aog.0000000000003869 via openalex
- doi:10.1016/j.bbmt.2013.07.020 via openalex
- doi:10.1515/ijamh.2011.013 via openalex
- doi:10.1111/1471-0528.14248 via openalex
- doi:10.15585/mmwr.rr7303a1 via openalex
- doi:10.1016/j.tem.2004.06.006 via openalex
- doi:10.3389/fendo.2020.00603 via openalex
- doi:10.1097/aog.0000000000003072 via openalex
- doi:10.1097/aog.0000000000004209 via openalex
- doi:10.1016/j.fertnstert.2012.07.1144 via openalex
- doi:10.1177/17455057241265081 via openalex
- doi:10.1034/j.1600-0412.1999.780810.x via openalex
- doi:10.1111/j.1528-1157.1991.tb05889.x via openalex
- doi:10.1016/j.contraception.2009.05.128 via openalex
- doi:10.1016/j.contraception.2004.06.011 via openalex
- doi:10.1002/14651858.cd000249.pub2 via openalex
- doi:10.1016/j.fertnstert.2019.09.037 via openalex
Source provenance
- openalex
- last seen: 2026-05-10T10:50:21.758254+00:00